Skip to content

CSF-Flow Control Valve-BUR

by Pudenz-Schulte Medical Research Corp.

510(k) K831678

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

1 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK831678 Date24 Jun 1983ClearedStatusActive

Recalls

1 recall · 1 ongoing · FDA

    • Ongoing Z-1117-2021 FDA Class II initiated 11 Jan 2021

    Potential for variation in radiopaque marking visibility under radiographic imaging for adjustable and fixed-pressure valves that are used in the management of hydrocephalus

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
P-S Medical Csf-Flow Control Valve-Bur
510(k) Number
FDA Product Code
JXG
Device Class
Class II
Regulation
21 CFR Part 882.5550
Advisory Committee
Neurology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a CSF-Flow Control Valve, classified as a Shunt, Central Nervous System and Components, designed to regulate cerebrospinal fluid (CSF) flow within ventricular shunt systems. It functions as a pressure-sensitive valve that controls the differential pressure between intracranial and distal drainage sites, ensuring proper CSF drainage while preventing over-drainage or blockage.

The valve is intended for use in neurosurgical shunt systems to manage hydrocephalus by maintaining controlled CSF flow. Supplied as a reusable component (as indicated by the regulatory submission), it is not sterile at time of shipment and requires sterilization prior to use. The device is categorized under FDA’s Device Class 2 and was cleared via a Traditional 510(k) pathway with a Substantially Equivalent determination by the Neurology Advisory Committee. No MRI safety or specific size variations are noted in the data.

Other devices from Pudenz-Schulte Medical Research Corp.

See all devices from Pudenz-Schulte Medical Research Corp. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Is this valve designed for single-use or can it be reused after sterilization?

    The valve is classified as a reusable component, as indicated by the regulatory submission. It is not sterile at the time of shipment and must be sterilized prior to use, allowing for multiple uses after proper sterilization procedures are followed.

  • What medical specialty is this device intended for, and how does it function within neurosurgical procedures?

    This device is categorized under the medical specialty of Neurology and is specifically designed for use in neurosurgical shunt systems. It functions as a pressure-sensitive valve that regulates cerebrospinal fluid (CSF) flow between the intracranial space and distal drainage sites, helping manage hydrocephalus by ensuring controlled drainage while preventing over-drainage or blockage.

  • Are there different sizes or models available for this valve, and if so, how are they distinguished?

    The provided data does not specify any size variations or distinct model numbers for this valve. All listed registration numbers correspond to the same device name (P-S MEDICAL CSF-FLOW CONTROL VALVE-BUR), suggesting a single standardized design without additional size or model differentiation.

  • How was this device’s regulatory clearance determined, and what pathway was used?

    The device was cleared via the Traditional 510(k) pathway with a Substantially Equivalent (SESE) determination by the Neurology Advisory Committee. This means the FDA found it to be comparable to a legally marketed predicate device, ensuring it meets safety and effectiveness standards for use in managing CSF flow in hydrocephalus treatment.

  • What storage or handling instructions should be followed for this valve before sterilization?

    Since the valve is not sterile at shipment, it must be stored in a clean, dry environment to prevent contamination before sterilization. The manufacturer’s instructions (not detailed here) should be followed for proper sterilization procedures prior to clinical use, as reuse is intended. Avoid exposure to moisture, extreme temperatures, or physical damage to maintain functionality.